11-hydroxyprogesterone has been researched along with Choriocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Latif, SA; Laurenzo, JL; Morris, DJ; Souness, GW | 1 |
1 other study(ies) available for 11-hydroxyprogesterone and Choriocarcinoma
| Article | Year |
|---|---|
11 alpha- and 11 beta-hydroxyprogesterone, potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2), confer marked mineralocorticoid activity on corticosterone in the ADX rat.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adrenalectomy; Animals; Choriocarcinoma; Corticosterone; Humans; Hydroxyprogesterones; Hydroxysteroid Dehydrogenases; Male; Microsomes, Liver; Natriuresis; Potassium; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1995 |